Vantedge Medical, a portfolio company of private equity firm Aterian Investment Partners, has acquired Hobson & Motzer, a US-based manufacturer of precision medical devices.
Financial terms of the deal were undisclosed.
The move is set to enhance Vantedge's position in the surgical stapler market and expand its consumable portfolio offering.
It will also strengthen the company’s position as a manufacturing partner across the nation to blue chip medical original equipment manufacturers (OEMs).
Founded in 1912, Hobson & Motzer owns facilities with various capabilities, including precision electrochemical machining, progressive stamping and coined wire, alongside tool and die capabilities.
Vantedge Medical chairman and CEO Brian King said: “I have worked with the Hobson & Motzer team for many years, and they consistently delivered best-in-class quality, service, value, and innovation.
“Their depth and scale of capabilities, backed by over 100 years of experience, perfectly complements the existing Vantedge capabilities, enhances the value we bring to the world's leading medical technology companies, and amplifies the difference we are making in the lives of patients and their families.”
Since Aterian acquired Vantedge in May 2018, the latter has expanded its portfolio by acquiring five medical technology businesses, establishing new production facilities, and investing in capital equipment capacity and human capital.
Vantedge now operates nine facilities in the US and employs more than 1,200 people.
Legal advice for the transaction was provided by Weil Gotshal & Manges to Aterian.
Vantedge Medical chief commercial officer Greg Santorno said: “Our union with Hobson & Motzer provides an expanded capability set that significantly increases the value we will deliver to our customers.
“The addition of precision progressive die stamping, unique value-add machining and assembly technologies, and a deep expertise in the manufacturing of surgical stapler anvils, complements our existing strengths serving the robotic-assisted surgery, surgical instrumentation, orthopaedics, ophthalmology, dental, drug delivery and medical diagnostics markets.”